Patent ID: 8357695

Claim:
A crystalline hydrate of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)- 1 -(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide, which is selected from the group consisting of the hydrate (a) which in an X-ray powder diffractogram at 25° C. and Cu—K α radiation, shows at least one reflex at the 2θ value of 11.6±0.2° and additionally at least five of the following reflexes, given as 2θ values: 5.1±0.2°, 10.1±0.2°, 10.8±0.2°, 13.9±0.2°, 15.1±0.2°, 16.1±0.2°, 17.9±0.2°, 20.2±0.2°, 24.5±0.2°, and the hydrate (b), which in an X-ray powder diffractogram at 25° C. and Cu—K α radiation, shows at least one reflex at the 2θ value of 12.1±0.2° and additionally at least five of the following reflexes, given as 2θ values: 5.2±0.2°, 10.2±0.2°, 10.9±0.2°, 14.0±0.2°, 14.6±0.2°, 15.3±0.2°, 19.2+0.2°, 19.9±0.2°, 20.5±0.2°, 24.7±0.2°, 26.7±0.2°, 27.8±0.2°.